NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
0.6472
Dollar change
-0.1048
Percentage change
-13.94
%
Index- P/E- EPS (ttm)-2.18 Insider Own0.85% Shs Outstand12.09M Perf Week-59.80%
Market Cap7.82M Forward P/E- EPS next Y- Insider Trans-98.39% Shs Float11.98M Perf Month21.11%
Enterprise Value18.67M PEG- EPS next Q- Inst Own3.19% Short Float2.12% Perf Quarter-70.58%
Income-25.02M P/S- EPS this Y- Inst Trans63.64% Short Ratio0.02 Perf Half Y-44.21%
Sales0.00M P/B2.07 EPS next Y- ROA-77.68% Short Interest0.25M Perf YTD-55.37%
Book/sh0.31 P/C5.93 EPS next 5Y- ROE-178.04% 52W High6.17 -89.51% Perf Year-
Cash/sh0.11 P/FCF- EPS past 3/5Y-166.64% -153.63% ROIC-650.98% 52W Low0.36 78.74% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility27.75% 17.49% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-462.45% Oper. Margin- ATR (14)0.22 Perf 10Y-
Dividend Ex-Date- Quick Ratio0.17 Sales Y/Y TTM-100.00% Profit Margin- RSI (14)49.68 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.22 EPS Q/Q-25.60% SMA204.56% Beta- Target Price-
Payout- Debt/Eq2.38 Sales Q/Q- SMA5017.44% Rel Volume0.10 Prev Close0.75
Employees2 LT Debt/Eq0.00 Earnings- SMA200-57.43% Avg Volume14.22M Price0.65
IPOSep 16, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume1,487,431 Change-13.94%
Jun-23-25 07:52AM
Mar-21-25 02:38PM
Feb-26-25 08:30AM
08:30AM
Jan-23-25 04:30PM
08:00AM Loading…
Nov-19-24 08:00AM
Nov-18-24 07:00AM
Nov-11-24 07:30AM
Oct-15-24 06:00AM
Oct-07-24 08:30AM
Sep-26-24 08:30AM
Sep-23-24 08:00AM
Sep-17-24 11:29AM
Sep-16-24 04:26PM
10:24AM
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DSS, INC.10% OwnerMay 22 '25Sale0.55115,60063,47645,400May 27 04:35 PM
DSS, INC.10% OwnerMay 27 '25Sale0.5445,40024,5300May 27 04:35 PM
DSS, INC.10% OwnerApr 04 '25Sale0.95890,800845,013161,100Apr 07 09:59 PM
Chan Heng Fai AmbroseDirectorApr 03 '25Sale0.49351,555174,0200Apr 07 05:18 PM
Chan Heng Fai AmbroseDirectorApr 02 '25Sale0.60884,776533,636351,555Apr 04 05:15 PM
Chan Heng Fai AmbroseDirectorApr 03 '25Sale0.67624,917416,4840Apr 04 05:15 PM
Chan Heng Fai AmbroseDirectorApr 04 '25Sale0.96180,000172,8000Apr 04 05:15 PM
Chan Heng Fai AmbroseDirectorApr 01 '25Sale1.172,226,9182,604,421734,058Apr 02 09:01 PM
Chan Heng Fai AmbroseDirectorMar 31 '25Sale1.03300,000308,4001,253,904Apr 02 09:01 PM
DSS, INC.10% OwnerMar 21 '25Sale3.30499,8001,649,5400Mar 28 05:25 PM
DSS, INC.10% OwnerMar 26 '25Sale3.1358,139182,1341,099,481Mar 28 05:25 PM
DSS, INC.10% OwnerMar 27 '25Sale2.5047,681119,2551,051,800Mar 28 05:25 PM
DSS, INC.10% OwnerMar 20 '25Buy1.5520031053,280Mar 24 08:00 PM
DSS, INC.10% OwnerMar 20 '25Sale4.6853,280249,3500Mar 24 08:00 PM
DSS, INC.10% OwnerDec 02 '24Sale2.90205853,080Mar 24 08:00 PM
Heuszel Frank DChief Executive OfficerDec 05 '24Buy2.265001,12997,344Dec 09 04:05 PM
Heuszel Frank DChief Executive OfficerNov 27 '24Buy2.615001,30596,844Dec 03 09:51 PM
Heuszel Frank DChief Executive OfficerNov 26 '24Buy2.611,0502,73996,344Dec 03 09:49 PM
DSS, INC.10% OwnerNov 18 '24Sale3.025,00015,08553,100Nov 22 04:33 PM
DSS, INC.10% OwnerNov 12 '24Sale2.765001,37858,300Nov 22 04:33 PM
DSS, INC.10% OwnerNov 13 '24Sale2.8020056058,100Nov 22 04:33 PM
DSS, INC.10% OwnerSep 18 '24Buy2.331,0002,33058,800Sep 19 07:07 PM
DSS, INC.10% OwnerSep 16 '24Buy2.6950,000134,50050,000Sep 18 08:53 PM
DSS, INC.10% OwnerSep 17 '24Buy2.407,80018,72057,800Sep 18 08:53 PM